Express Scripts

INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients

Retrieved on: 
Monday, October 9, 2023
Food, Hope, Type, Express, Express Scripts, PBM, Risk, Hospital, FDA, Medicare, Heart failure, Chronic kidney disease, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lexicon Pharmaceuticals, Patient, The Guardian Life Insurance Company of America, Pharmaceutical industry, Dietary supplement

THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Express Scripts, the pharmacy benefits management (PBM) business of The Cigna Group's Evernorth, has determined that it will place INPEFA on its Premier Access and Premier Performance national formularies for Medicare patients on November 1, 2023. This placement will provide access to INPEFA for Express Scripts Medicare patients in plans that utilize these formularies and who meet the parameters of INPEFA’s FDA-approved indication.

Key Points: 
  • Express Scripts has determined that it will list INPEFA as a preferred product on Medicare national formularies on November 1, 2023
    THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Express Scripts, the pharmacy benefits management (PBM) business of The Cigna Group's Evernorth, has determined that it will place INPEFA on its Premier Access and Premier Performance national formularies for Medicare patients on November 1, 2023.
  • This placement will provide access to INPEFA for Express Scripts Medicare patients in plans that utilize these formularies and who meet the parameters of INPEFA’s FDA-approved indication.
  • “We are proud to announce this significant milestone for INPEFA and are appreciative of the expeditious steps Express Scripts has taken to make INPEFA available to patients who need it the most,” said Lonnel Coats, Lexicon’s chief executive officer.
  • INPEFA is currently commercially available in the U.S.

Walgreens Boots Alliance Appoints Tim Wentworth as Chief Executive Officer

Retrieved on: 
Wednesday, October 11, 2023
Retail, Health, Consumer, Seniors, Specialty, General Health, Multimedia, Senior, PepsiCo, Walgreens Boots Alliance, Pharmacy, Human resources, Express Scripts, Organization, Stefano Pessina, Ginger, WBA, Mary Kay, Growth, Cornell University, Medco, Monroe Community College, Patient, Health care, Management, Cigna, Accredo

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Tim Wentworth as the company’s new Chief Executive Officer, effective on October 23.

Key Points: 
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Tim Wentworth as the company’s new Chief Executive Officer, effective on October 23.
  • Mr. Wentworth will also join the WBA Board of Directors upon assuming the role.
  • View the full release here: https://www.businesswire.com/news/home/20231011544834/en/
    Tim Wentworth named Walgreens Boots Alliance CEO (Photo: Business Wire)
    Most recently, as founding CEO of Evernorth, Cigna’s health services organization that partners with health plans, employers and government organizations, Mr. Wentworth brought together health service capabilities including care provision, pharmacy solutions and benefits management.
  • I believe in WBA’s vision to be the leading partner in reimagining local healthcare and well-being for all,” said Mr. Wentworth.

Komodo Health Appoints Julia Goebel, Brad Kelley to Senior Marketing and Data Strategy Positions

Retrieved on: 
Tuesday, October 3, 2023
Technology, Biotechnology, Health, Venture Capital, Other Health, Professional Services, Marketing, Software, General Health, Data Analytics, Communications, Health Technology, Data Management, Security, University, Senior, Executive education, Risk management, Journalism, Washington University in St. Louis, Eli Lilly, Organization, Cardinal Health, Bachelor of Arts, State, Express Scripts, Patient, Growth, Entrepreneurship, Hospira, Julia, Electricity, Pfizer, Disease, Pharmaceutical industry, Science, Cigna, Economics, Komodo

Julia Goebel was named Senior Vice President of Marketing, and Brad Kelley was named General Manager of MapEnhance.

Key Points: 
  • Julia Goebel was named Senior Vice President of Marketing, and Brad Kelley was named General Manager of MapEnhance.
  • As Komodo’s new head of marketing, Julia will deepen the company’s strategic approach to key customer segments, optimizing market awareness for Komodo’s unique full-stack technology strategy and differentiated data and technology products.
  • She will bring to Komodo her extensive marketing experience in software and subscription businesses, both publicly traded and privately held.
  • “I am thrilled to welcome both Julia and Brad to Komodo,” said Web Sun, Co-Founder and President of Komodo Health.

Dr. Steven Goldberg Joins Goodroot as Chief Medical Officer

Retrieved on: 
Tuesday, September 19, 2023
Sola, Quest Diagnostics, WellCare, Health, Express Scripts, Adalimumab, MBA, MD, Aetna, Modern Healthcare, Management, Quest

COLLINSVILLE, Conn., Sept. 19, 2023 /PRNewswire/ -- Steven Goldberg, MD, MBA has been named chief medical officer at Goodroot , a community of companies dedicated to increasing access and affordability in healthcare.

Key Points: 
  • COLLINSVILLE, Conn., Sept. 19, 2023 /PRNewswire/ -- Steven Goldberg, MD, MBA has been named chief medical officer at Goodroot , a community of companies dedicated to increasing access and affordability in healthcare.
  • In this role, Dr. Goldberg will support Goodroot's efforts to bring solutions to market that enhance healthcare outcomes while simultaneously reducing costs.
  • His expertise will be particularly valuable for Sola Health , a Goodroot company with a comprehensive offering of self-funded health plans.
  • Dr. Goldberg will be an integral part of the team as Goodroot continues to implement strategies to improve member health outcomes."

GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions

Retrieved on: 
Wednesday, September 13, 2023
Online Retail, Health, Supermarket, General Health, Specialty, Department Stores, Public Relations, Investor Relations, Pharmaceutical, Communications, Convenience Store, Retail, Insurance, Doctor, Prescription, Pharmacy, Sale, PBM, Express Scripts, Drug, Patient, CVS Caremark, Health insurance, Pharmaceutical industry, GoodRx

Now, when an eligible MedImpact member fills a prescription for a generic medication, it will automatically compare their benefit and the GoodRx price and then deliver the lowest one.

Key Points: 
  • Now, when an eligible MedImpact member fills a prescription for a generic medication, it will automatically compare their benefit and the GoodRx price and then deliver the lowest one.
  • In addition, members will benefit from the seamless data integration this program provides.
  • Through these programs with CVS Caremark, Express Scripts, and MedImpact, GoodRx savings are seamlessly integrated at point-of-sale with three major PBMs that reach over 60% of insured lives.
  • This new program will become available to eligible MedImpact members starting January 1, 2024.

Surescripts Names Lynne Nowak as First Chief Data and Analytics Officer

Retrieved on: 
Tuesday, September 12, 2023
Data Management, Health, Technology, Health Technology, General Health, Networks, Pharmaceutical, Trial of the century, Intelligence, Organization, Express Scripts, Patient, Lark Health, Surescripts, Real-time, Data science, Risk management, Pharmaceutical industry, Cigna, Research

, as its first Chief Data and Analytics Officer.

Key Points: 
  • , as its first Chief Data and Analytics Officer.
  • In this role, Nowak’s team will work across the Surescripts Network Alliance to optimize the value of the data delivered across the network.
  • “Healthcare will never stop evolving and I’m excited to join Surescripts, bringing my experience as a clinician but also a data and analytics expert, to continue leading innovations in health information technology and advancing interoperability,” said Lynne Nowak, Chief Data and Analytics Officer for Surescripts.
  • Most recently, she served as Chief Medical Officer at Lark Health where she led Business Insights, Analytics Engineering, Clinical Studies and Research, and Clinical Strategy.

Visory Health Empowers Women & Caregivers to Create Healthier Communities Through Lower Cost Prescription Medications

Retrieved on: 
Wednesday, September 6, 2023
Retail, Technology, Other Consumer, General Health, Women, Seniors, Online Retail, Discount, Variety, Parenting, Men, Supermarket, Other Technology, Family, Consumer, Health, Mobile, Wireless, Kroger, Google Wallet, Club, Google Play, Friends, Pharmacy, IQVIA, Wealth, Robot App Store, Woman, Prescription, Stop & Shop, Express Scripts, Walmart, Patient, Apple, WHO, Wallet, Courage, App Store (iOS/iPadOS), Empowerment, Caregiver, Pharmaceutical industry, Visori, Publix

Visory Health is transforming the way everyone, including women, caregivers and underserved communities access medications through a simple, patient-first platform that provides lower prices on prescriptions.

Key Points: 
  • Visory Health is transforming the way everyone, including women, caregivers and underserved communities access medications through a simple, patient-first platform that provides lower prices on prescriptions.
  • In just over one year since the company launched, Visory Health has enabled more than 3.26 million customers to access their essential medications while saving them over $4 billion.
  • According to healthcare analytics company IQVIA, Visory Health is already the fourth largest discount card demonstrating the void it is quickly filling in the prescription marketplace.
  • “After decades of experience in the prescription pricing and healthcare industry, the reality is that women and caregivers continue to be overlooked,” said Susan Lang, Visory Health Founder and CEO.

Double 40 Under 40 Winners for McCann in 2023

Retrieved on: 
Tuesday, September 5, 2023
McCann, Professional, Teaching, Woman, Marketing, Solution architecture, LED, Express Scripts, UC, Engineering, Commercial, Anheuser-Busch, Shawn, Video game

BOSTON, Sept. 5, 2023 /PRNewswire/ -- For nine years in a row, team members with McCann have won a prestigious Commercial Integrator 40 Under 40 award .

Key Points: 
  • BOSTON, Sept. 5, 2023 /PRNewswire/ -- For nine years in a row, team members with McCann have won a prestigious Commercial Integrator 40 Under 40 award .
  • This time around, McCann is proud to celebrate two 40u40 winners, Ben Slattery and Shawn Pelow.
  • Shawn Pelow is an exemplary member of the commercial AV industry and a skilled Site Foreman at McCann Systems.
  • Shawn says, "I am honored and humbled to be one of the 40 amazing men and women that Commercial Integrator has selected for 40 Under 40 of 2023.

Cigna Under Fire by AHF for Unethical Pharmacy Benefit Management Practices

Retrieved on: 
Wednesday, August 23, 2023
Women, Pharmaceutical, AIDS, Men, General Health, Health, Consumer, Other Health, AHF, HIV, Pharmacy, Public, Accredo, PBM, Express Scripts, Patient, AIDS Healthcare Foundation, ESI, Express, Health insurance, Health care, Cigna

Healthcare advocates from across the country affiliated with AIDS Healthcare Foundation (AHF) will protest Cigna – and, in particular, its pharmacy benefit manager (PBM) Express Scripts (ESI) – for its unethical practices that disrupt patient care and harm patient access to their chosen pharmacies.

Key Points: 
  • Healthcare advocates from across the country affiliated with AIDS Healthcare Foundation (AHF) will protest Cigna – and, in particular, its pharmacy benefit manager (PBM) Express Scripts (ESI) – for its unethical practices that disrupt patient care and harm patient access to their chosen pharmacies.
  • Cigna purchased ESI, one of the country’s largest PBMs, in 2018.
  • As the controller of drug benefits for more than 100 million people in the U.S., Express Scripts can impose take-it-or-leave it terms with impunity.
  • Express Scripts’ goal is to sever providers’ relations with their patients and force those patients into Express Scripts’ own specialty mail order pharmacy construct, Accredo.

Napoli Shkolnik Files Insulin Pricing Scheme Complaint on Behalf of Cattaraugus County, New York Against 19 Major Players in Pharma Industry

Retrieved on: 
Thursday, August 17, 2023
Professional Services, Medical Supplies, Health, Diabetes, Legal, Pharmaceutical, Lawsuit, Insulin, Gestational diabetes, Mariya Shkolnik, Pharmacy, Racketeer Influenced and Corrupt Organizations Act, Express Scripts, UnitedHealth Group, Sanofi, Eli Lilly and Company, Prediabetes, Plaintiff, CVS Caremark, Pharmaceutical industry

Cattaraugus County claims the defendants - all major players in the pharma industry - engineered these price increases via an opaque, conspiratorial kickback scheme (referred to in the lawsuit as the “Insulin Pricing Scheme”), which has exponentially increased their profits at the expense of payors like Plaintiff and its plan members.

Key Points: 
  • Cattaraugus County claims the defendants - all major players in the pharma industry - engineered these price increases via an opaque, conspiratorial kickback scheme (referred to in the lawsuit as the “Insulin Pricing Scheme”), which has exponentially increased their profits at the expense of payors like Plaintiff and its plan members.
  • The Insulin Pricing Scheme is a multibillion-dollar industry with many of the corporate defendants listed in the top 20 of the 2022 Fortune 500 list.
  • The price range for insulin today can range from $300 to $700 despite costing manufacturers as little as $2 to produce.
  • Approximately 1.7 million people in New York, or 10.7% of the adult population, have diabetes.